Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
![treatment treatment](https://velocityclinical.com/wp-content/uploads/bb-plugin/cache/treatment-portrait-c255e08eb78c94fee9635d20155d5f0b-opa5k7d6i3ht.jpg)
![mother-and-child-2 mother-and-child-2](https://velocityclinical.com/wp-content/uploads/bb-plugin/cache/mother-and-child-2-square-34d341eeea3f3e95edb1bbfbdbf9f17d-dy8kaxbfzij7.jpg)
![Hallandale Hallandale](https://velocityclinical.com/wp-content/uploads/bb-plugin/cache/Hallandale-landscape-70a39f7516508d4b3fc64f76110e7bce-i5e806f4dqlp.jpg)
![Velocity-team-office Velocity-team-office](https://velocityclinical.com/wp-content/uploads/bb-plugin/cache/Velocity-team-office-1024x683-landscape-1c476bf66b1f40d6bfe750936b71c685-p6ogkyh0xj53.jpg)
News
ACRP Article: Providing the Blueprint for Gen AI Adoption in Clinical Trials
In his latest article for the Association of Clinical Research Professionals (ACRP), Paul Evans outlines how integrated site organizations can pave the way for AI adoption and generate tangible value … Read more
Closing Trust Gaps: The Economic Case for Enhancing Health Equity in Clinical Trials
The pandemic left many notable developments in its wake, not least the increased focus on improving diversity in clinical trials. This issue was thrust into the spotlight during Operation Warp … Read more
Nick Spittal Comments on Velocity’s Membership With Advarra’s Gene Therapy Ready Site Network
As Nick Spittal states in this Advarra press release, membership in the Gene Therapy Ready (GTR) site network “allows Velocity to start studies over a month faster and provides a … Read more
VISION Reaches $2.5 Million in Patient Stipends Paid Globally
Another major milestone for Velocity — more than $2.5 million in patient study stipends have been paid globally through our VISION Engage app! With VISION Engage, patients can seamlessly manage … Read more